spacer
home > pmps > autumn 2017 > making the switch
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Making the Switch

The global pharmaceutical manufacturing sector revenue is estimated to increase to around $1,226 billion by 2018. To remain competitive in such a large market, these organisations must optimise processes to create low-expense products without compromising quality. The adoption of continuous manufacturing will offer the industry many benefits.

Pharma production is a well-established sector that provides high-quality and affordable medication to the population. However, manufacturers often rely on older processes rather than adapting to meet the growing needs of consumers.

Traditionally, batch manufacturing produces the majority of drugs sold worldwide a method that isolates each process. Workers will handle the product at each stage, sending it to be tested in laboratories before the next step. While this works effectively, receiving the final item may take months. Companies are looking for new solutions to reduce costs, environmental impact and development time.

In the boom of Industry 4.0, many sectors, such as chemicals and gas, have implemented more advanced technology to optimise production. Integrated automation systems can streamline an assembly line to efficiently create medication and devices frequently, with little human interaction. Continuous manufacturing is an advancement that developers should utilise to reap the same benefits as these industries.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Jonathan Wilkins is Marketing Director at EU Automation and is also one of the most prolific Industry 4.0 writers in the industrial automation sector. A professional brand advocate and commercial marketing strategist, he has been part of the company since its humble beginnings in 2009 and has over a decade of experience in marketing.
spacer
Jonathan Wilkins
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

PCI Announces Expansion of its Industry-Leading Cold Chain Infrastructure with Dedicated Minus 40 degrees C Facility

Philadelphia, USA August 29, 2018 PCI Pharma Services (PCI), a full-service provider of specialist outsourced drug manufacturing, Clinical trial services, and commercial packaging to the global healthcare industry, is pleased to announce the completion of a purpose built -40C storage and distribution facility at its North American Clinical Services Center of Excellence.
More info >>

White Papers

PROTEIN:PROTEIN INTERACTION ANALYSIS

IBA GmbH

Groth et al., 2007 and Jasencakova et al., 2010 Protein:protein-interactions (PPI) govern almost all important processes in living organisms. Thus, their rapid and accurate determination and investigation is a major challenge in life sciences. The extremely efficient and fast One-STrEP (Twin-Strep) system is suitable for the isolation of functional protein complexes and subsequent mass spectrometry analysis leads to the identification of protein complex components (Junttila et al., 2005) as it is shown in the following studies.
More info >>

 
Industry Events

RDD Asia 2018

14-15 November 2018, Grand Hyatt Kochi, Kerala, India

A must-attend meeting for pulmonary and nasal researchers, inhaled product developers and vendors active in this important pharmaceutical niche.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement